Circular Bioengineering (FWF CoE17), opens an external URL in a new window

At the Cluster of Excellence Circular Bioengineering, our mission is to drive a paradigm shift in how goods are produced, consumed, and renewed. By harnessing cutting-edge research in molecular biosciences and biotechnology, we design and engineer bio-based materials that are sustainable, efficient, and waste-free—pushing the boundaries towards a fossil fuel-free world. We contribute by developing and applying functional multi-omics workflows aiming to discover and improve biocatalysts.

Microbiomes drive planetary health (microPlanet) (FWF CoE7), opens an external URL in a new window

The Cluster of Excellence "Microbiomes Drive Planetary Health" unites microbiome research in Austria, which already possesses strengths in many highly relevant areas of microbiome research, from the human microbiome to global change microbiology. Our goal is to understand how microbes underpin planetary health and to unlock their potential to improve it. We contribute by developing and applying multi-omics and activity-based metaproteomics workflows aiming to provide functional insight into host microbiome interactions.

Integrated digitalized production of protein therapeutics (DigiTherapeutX) (FWF FG12), opens an external URL in a new window

We are part of a research group from University of Salzburg, BOKU University Vienna and TU Wien aiming to characterize molecular attributes of biopharmaceuticals in dependence of critical process parameters and linking them via host cell omics and computational modeling to increase our understanding of the bioprocesses for the production of biotherapeutics.

International MSCA-Cofund Doctoral Program: Engineering for Life Sciences (ENROL)

(Marie Skłodowska-Curie grant agreement No 101034277)

ENROL is an interdisciplinary Marie Skłodowska-Curie COFUND doctoral program at Technische Universität Wien that is set up to educate and train a new generation of 20 high achieving early stage researchers (ESRs) to study and develop novel technologies and engineering solutions for the life sciences. Our PhD project (P22, opens an external URL in a new window) focuses on the design and application of functional proteomic approaches to study molecular and cellular drug (off) target effects of gliflozins.

SFB Lipid hydrolysis, opens an external URL in a new window (FWF F73)

The overall goal of the SFB Lipid hydrolysis consortium is to assemble Austrian research groups with the strongest expertise from Graz and Vienna to investigate the biochemistry, cell biology, and physiology of lipid degradation pathways. Our project within the SFB aims to investigate the impact of lipolysis in cancer cell lines and in samples from non-small lung cancer cell patients and investigate the role of lipolysis in hepatic stellate cell activation.

Finished projects (in 2024):

Identification and characterisation of Ribosomally synthesized and post-translationally modified peptides (RiPPs) (FWF P34036)

The aim of this stand-alone FWF project is the identification and characterisation of unknown fungal RiPPs using complementary proteomics and metabolomics approaches. 

International PhD Program: Metabolic and Cardiovascular Disease (DK-MCD), opens an external URL in a new window (FWF W1226)

Our DK-MCD-students analyze the molecular (phospho)proteomic, metabolic, and lipid signaling networks related to lipolysis and fatty acid metabolism to understand the (dys)regulation of lipid metabolism in health, cancer, and lipid-associated diseases.

Back to main page